News, 28 January 2025
The fleet management company trackNOW has received an undisclosed investment from the Poonawalla Group.
trackNOW, which was founded in 2016 by Pooja and Suyash Khemka, provides logistics platforms and merchants with fleet management and tracking solutions. TrackNOW’s real-time monitoring solutions provide insight into the location, status, and condition of their clients’ assets by utilizing technologies including cloud computing, GPS, and the Internet of Things (IoT).
According to the Poonawalla Group, it plans to increase the size of its holdings and make large investments in additional “notable and high-potential ventures” soon. It intends to concentrate on supporting businesses in a variety of industries and provide them with networking opportunities, industry knowledge, and mentorship.
The statement was made in the midst of several changes in the Indian logistics industry.
About trackNow
trackNOW is a logistics and supply chain management platform that focuses on enhancing visibility and efficiency in tracking shipments. With its user-friendly interface, trackNOW allows businesses to monitor the status of their deliveries in real-time, facilitating better decision-making and improving customer satisfaction. The platform often integrates with existing logistics systems, providing users with updates on delivery times, route optimization, and potential delays. By centralizing tracking information, trackNOW aims to streamline operations for shippers and improve transparency in the supply chain. It’s particularly valuable for businesses that handle high volumes of shipments and require accurate tracking to manage their logistics effectively.
About Poonawalla Group
The Poonawalla Group is a prominent Indian conglomerate with diversified interests across various sectors, including pharmaceuticals, biotechnology, real estate, and financial services. Founded in the 1960s by Cyrus Poonawalla, the group is best known for its leading entity, Serum Institute of India, which is the world’s largest manufacturer of vaccines. This organization plays a critical role in immunization globally, particularly highlighted during the COVID-19 pandemic for its production of the AstraZeneca vaccine.
The Poonawalla Group emphasizes innovation and quality in its operations, contributing significantly to public health initiatives and the pharmaceutical landscape. Beyond healthcare, the group also invests in other ventures, including hospitality and infrastructure, positioning itself as a multifaceted player in both domestic and international markets. The Poonawalla Group is recognized not only for its business achievements but also for its commitment to corporate social responsibility, particularly in healthcare and education.
